secwatch / observer
8-K filed December 9, 2022, 6:59 PM ET ticker SPRY CIK 0001671858
leadership confidence high sentiment neutral materiality 0.55

ARS Pharmaceuticals appoints Brian Dorsey as COO; salary increased to $410,000

ARS Pharmaceuticals, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Brian T. Dorsey

Chief Operations Officer
SPRY · ARS Pharmaceuticals, Inc.
Effective
2022-12-06
Filed
December 9, 2022, 6:59 PM ET
Effective as of December 6, 2022, ARS Pharmaceuticals, Inc. (the “Company”) appointed Brian T. Dorsey, MSc, as Chief Operations Officer of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brian T. Dorsey was appointed as Chief Operations Officer at ARS Pharmaceuticals, Inc..

Action
appointed
Role
Chief Operations Officer
Exact text from the filing
Effective as of December 6, 2022, ARS Pharmaceuticals, Inc. (the “Company”) appointed Brian T. Dorsey, MSc, as Chief Operations Officer of the Company.
View on SEC.gov

ARS Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-22-301873
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.